http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0470184-A4

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6839
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-1063
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6425
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-91
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-577
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-155
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K19-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-705
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-06
filingDate 1990-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1992-10-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-0470184-A4
titleOfInvention Antibodies specific for cd4-binding domain of hiv
abstract A particular epitope located within the CD4-binding region of gp120 of HIV-1, and antibody specific for the epitope which can inhibit diverse strains and isolates of the virus, is disclosed. The antibody can be used in immunotherapy of HIV-1 infection. In addition, neutralizing antibody against this conserved epitope can be used in immunoconjugates to target virally-infected cells.
priorityDate 1989-04-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8809181-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0279688-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-8707616-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24186254
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23830
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226398800
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4784
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21292785
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID440459
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID19649
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413143
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1134
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394880
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226399961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226410798
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396327
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44630569
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427144
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396326
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222528
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11218679
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4428483
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3034398
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395848
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID37542
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395500
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226403335
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15764346
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID100682
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420717
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409524
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2154
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11333924
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID41206
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226420718
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400531
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400532
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226400530
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406715
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409525
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412246

Total number of triples: 74.